Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Positron Emission Tomography (PET) Imaging in Staging Potentially Surgically Resectable Non-small Cell Lung Cancers: A Prospective Multicentre Randomized Clinical Trial

NCT00136890 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.

NCT NCT00136890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00136890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Positron Emission Tomography (PET) Imaging in Staging Potentially Surgically Resectable Non-small Cell Lung Cancers: A Prospective Multicentre Randomized Clinical Trial
Lead sponsor
Ontario Clinical Oncology Group (OCOG)
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
January 31, 2013
Enrollment
337 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung carcinoma